hypericum and Sunburn

hypericum has been researched along with Sunburn* in 3 studies

Trials

1 trial(s) available for hypericum and Sunburn

ArticleYear
St. John's wort treatment in women bears risks beyond pharmacokinetic drug interactions.
    Archives of toxicology, 2016, Volume: 90, Issue:4

    We analyzed adverse events in a clinical phase I trial to assess dose-dependent metabolic effects of St. John's wort co-administered with rifampicin in 12 healthy volunteers. Within 3-6 days after increasing the St. John's wort dose from 300 to 600 mg TID, five of six female participants developed ambient temperature-dependent allodynia and paresthesia in sun-exposed areas (back of the hands and perioral and nasal area). Aggravation of symptoms resulted in persistence of paresthesia and phototoxic erythrodermia. None of the male participants showed any of these effects. Gender, duration of treatment, dose, and solar exposure seem to be extrinsic and host factors facilitating St. John's wort-induced neuropathy. The risk to develop this adverse effect is almost exclusively present in women.

    Topics: Drug Interactions; Female; Humans; Hyperalgesia; Hypericum; Male; Paresthesia; Plant Extracts; Rifampin; Sunburn

2016

Other Studies

2 other study(ies) available for hypericum and Sunburn

ArticleYear
[Sunburn -- or yet not?].
    MMW Fortschritte der Medizin, 2006, Sep-21, Volume: 148, Issue:38

    Topics: Aged; Aged, 80 and over; Anthracenes; Dermatitis, Contact; Diagnosis, Differential; Humans; Hypericum; Male; Perylene; Sunburn

2006
Influence of GSTT1 and GSTM1 genotypes on sunburn sensitivity.
    American journal of pharmacogenomics : genomics-related research in drug development and clinical practice, 2002, Volume: 2, Issue:2

    Exposure to sunlight may cause sunburn, skin cancer or phototoxic reactions to certain drugs such as Hypericum extract. All these are ultraviolet B (UVB)-mediated reactions which may be modulated by individual genetic susceptibility. UVB exposure results in oxidative stress. Many products of oxidative stress are detoxified by glutathione-S-transferases mu 1 (GSTM1) and theta 1 (GSTT1). Deletion polymorphisms (genotype *0/*0) of GSTM1 and GSTT1 occur in 50% and 20% of Caucasians, respectively. By affecting the individual ability to detoxify oxidative stress-related products, they may influence the severity of the cutaneous photoreaction.. Minimal erythema doses (MED) of UVB irradiation on the skin were determined in 110 subjects who were selected according to their GSTT1 genotype (28 GSTT1*0/*0, 54 GSTT1*A/*0, and 28 GSTT1*A/*A). Genotypes were detected with novel polymerase chain reaction (PCR) assays that allow the differentiation between homozygous and heterozygous GSTT1 and GSTM1 deletions.. In the absence of GSTT1 enzyme, the susceptibility of individuals to UVB-induced inflammatory skin reactions increased significantly (p = 0.02, ANCOVA). 'Gene-equivalents' were calculated from the number of functional GSTM1 and GSTT1 alleles as a measure of the gene-dose. UVB sensitivity correlated with gene dose up to a threshold above which additional GSTT1 or GSTM1 alleles did not provide additional protection. Volunteers who were homozygously deficient in GSTT1 and GSTM1 were most sensitive to UVB. Interestingly, individuals with high GSTM1 gene-doses showed increased photosensitization after administration of Hypericum extract (St. John's wort).. Individuals harboring the *0/*0 genotype of GSTT1 and/or GSTM1 showed enhanced UVB-induced cutaneous damage. Moreover, GST genotypes modulated Hypericum-induced photosensitization.

    Topics: Adolescent; Adult; Analysis of Variance; Erythema; Female; Genotype; Glutathione Transferase; Humans; Hypericum; Male; Middle Aged; Polymorphism, Genetic; Statistics, Nonparametric; Sunburn

2002